Privia Deferred Long Term Liab from 2010 to 2024
| PRVA Stock | USD 21.69 0.15 0.69% |
Deferred Long Term Liabilities | First Reported 2010-12-31 | Previous Quarter 2.1 M | Current Value 2 M | Quarterly Volatility 261.1 K |
Check Privia Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Privia Health's main balance sheet or income statement drivers, such as Net Interest Income of 7 M, Depreciation And Amortization of 3.3 M or Interest Expense of 8.8 M, as well as many indicators such as Price To Sales Ratio of 2.94, Dividend Yield of 0.0 or PTB Ratio of 4.55. Privia financial statements analysis is a perfect complement when working with Privia Health Valuation or Volatility modules.
Privia | Deferred Long Term Liab |
Latest Privia Health's Deferred Long Term Liab Growth Pattern
Below is the plot of the Deferred Long Term Liab of Privia Health Group over the last few years. It is liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue. Privia Health's Deferred Long Term Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Privia Health's overall financial position and show how it may be relating to other accounts over time.
| Deferred Long Term Liab | 10 Years Trend |
|
Deferred Long Term Liab |
| Timeline |
Privia Deferred Long Term Liab Regression Statistics
| Arithmetic Mean | 2,504,667 | |
| Geometric Mean | 2,491,222 | |
| Coefficient Of Variation | 10.43 | |
| Mean Deviation | 234,400 | |
| Median | 2,700,000 | |
| Standard Deviation | 261,120 | |
| Sample Variance | 68.2B | |
| Range | 700K | |
| R-Value | (0.87) | |
| Mean Square Error | 17.4B | |
| R-Squared | 0.76 | |
| Significance | 0.000021 | |
| Slope | (51,000) | |
| Total Sum of Squares | 954.6B |
Privia Deferred Long Term Liab History
About Privia Health Financial Statements
Privia Health stakeholders use historical fundamental indicators, such as Privia Health's Deferred Long Term Liab, to determine how well the company is positioned to perform in the future. Although Privia Health investors may analyze each financial statement separately, they are all interrelated. For example, changes in Privia Health's assets and liabilities are reflected in the revenues and expenses on Privia Health's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Privia Health Group. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Deferred Long Term Liabilities | 2.1 M | 2 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Privia Health Group offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Privia Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Privia Health Group Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Privia Health Group Stock:Check out the analysis of Privia Health Correlation against competitors. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Privia Health. If investors know Privia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Privia Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.38) | Earnings Share 0.11 | Revenue Per Share 14.435 | Quarterly Revenue Growth 0.049 | Return On Assets 0.0077 |
The market value of Privia Health Group is measured differently than its book value, which is the value of Privia that is recorded on the company's balance sheet. Investors also form their own opinion of Privia Health's value that differs from its market value or its book value, called intrinsic value, which is Privia Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Privia Health's market value can be influenced by many factors that don't directly affect Privia Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Privia Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Privia Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Privia Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.